Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • cancer

    Tag: cancer

    You Searched For "cancer"
    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    Meghna A Singhania22 May 2019 5:25 PM IST
    New Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Farhat Nasim17 May 2019 1:45 PM IST
    Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added. NEW DELHI: Shilpa...
    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Medical Dialogues Bureau14 May 2019 9:47 AM IST
    The USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    Medical Dialogues Bureau10 May 2019 9:00 AM IST
    The treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
    AstraZeneca ties up with Transgene to develop viral immunotherapies

    AstraZeneca ties up with Transgene to develop viral immunotherapies

    Garima2 May 2019 9:25 AM IST
    AstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 9:35 AM IST
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    AstraZeneca Q1 sales beat estimates on cancer drugs

    AstraZeneca Q1 sales beat estimates on cancer drugs

    Garima28 April 2019 9:15 AM IST
    AstraZeneca, fresh off an oncology deal with Japan's Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009,...
    Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

    Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

    Farhat Nasim22 April 2019 9:30 AM IST
    New Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
    Sandoz to commercialize Rizmoic to treat opioid-induced constipation

    Sandoz to commercialize Rizmoic to treat opioid-induced constipation

    Farhat Nasim13 April 2019 9:21 AM IST
    HOLZKIRCHEN: Sandoz recently announces that it has signed an agreement with Shionogi & Co Ltd for commercialization of Rizmoic (naldemedine) in...
    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Meghna A Singhania11 April 2019 10:50 AM IST
    Mumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
    Sun Pharma launches cancer drug INFUGEM in US market

    Sun Pharma launches cancer drug INFUGEM in US market

    Farhat Nasim9 April 2019 10:05 AM IST
    Sun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Farhat Nasim6 April 2019 9:40 AM IST
    New Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok